Major Companies for Painless Blood Glucose Monitoring Device Market: Nemaura Medical, Occuity, Tianjin Guyufan Biological Technology, GlucoActive, Afon Technology, Gluco-Wise, RSP System, Know Labs, META, Abbott U.S., MediWise, Ascensia Diabetes Care, Dexcom, Inc., Medtronic plc, Sanofi Novo Nordisk, Insulet Corporation, Senseonics.
Global Painless Blood Glucose Monitoring Device Market Size was estimated at USD 137150 million in 2022 and is projected to reach USD 164720.557557227 million by 2028, exhibiting a CAGR of 3.1% during the forecast period.
Global Painless Blood Glucose Monitoring Device Market Overview And Scope:
The Global Painless Blood Glucose Monitoring Device Market Report 2024 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Painless Blood Glucose Monitoring Device utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2024 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Painless Blood Glucose Monitoring Device Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Painless Blood Glucose Monitoring Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Painless Blood Glucose Monitoring Device market.
Global Painless Blood Glucose Monitoring Device Market Segmentation
By Type, Painless Blood Glucose Monitoring Device market has been segmented into:
Subcutaneous Implant Type
Vacuum Blood Collection Type
Wearable Type
Others
By Application, Painless Blood Glucose Monitoring Device market has been segmented into:
Hospitals
Homecare
Clinics
Regional Analysis of Painless Blood Glucose Monitoring Device Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Painless Blood Glucose Monitoring Device Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Painless Blood Glucose Monitoring Device market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Painless Blood Glucose Monitoring Device market.
Major Companies Covered in Painless Blood Glucose Monitoring Device market are:
Nemaura Medical
Occuity
Tianjin Guyufan Biological Technology
GlucoActive
Afon Technology
Gluco-Wise
RSP System
Know Labs
META
Abbott U.S.
MediWise
Ascensia Diabetes Care
Dexcom
Inc.
Medtronic plc
Sanofi Novo Nordisk
Insulet Corporation
Senseonics
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Painless Blood Glucose Monitoring Device Market by Type
5.1 Painless Blood Glucose Monitoring Device Market Overview Snapshot and Growth Engine
5.2 Painless Blood Glucose Monitoring Device Market Overview
5.3 Subcutaneous Implant Type
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Subcutaneous Implant Type: Geographic Segmentation
5.4 Vacuum Blood Collection Type
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Vacuum Blood Collection Type: Geographic Segmentation
5.5 Wearable Type
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Wearable Type: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: Painless Blood Glucose Monitoring Device Market by Application
6.1 Painless Blood Glucose Monitoring Device Market Overview Snapshot and Growth Engine
6.2 Painless Blood Glucose Monitoring Device Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Homecare
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Homecare: Geographic Segmentation
6.5 Clinics
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Clinics: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Painless Blood Glucose Monitoring Device Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Painless Blood Glucose Monitoring Device Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Painless Blood Glucose Monitoring Device Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 NEMAURA MEDICAL
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 OCCUITY
7.4 TIANJIN GUYUFAN BIOLOGICAL TECHNOLOGY
7.5 GLUCOACTIVE
7.6 AFON TECHNOLOGY
7.7 GLUCO-WISE
7.8 RSP SYSTEM
7.9 KNOW LABS
7.10 META
7.11 ABBOTT U.S.
7.12 MEDIWISE
7.13 ASCENSIA DIABETES CARE
7.14 DEXCOM
7.15 INC.
7.16 MEDTRONIC PLC
7.17 SANOFI NOVO NORDISK
7.18 INSULET CORPORATION
7.19 SENSEONICS
Chapter 8: Global Painless Blood Glucose Monitoring Device Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Subcutaneous Implant Type
8.2.2 Vacuum Blood Collection Type
8.2.3 Wearable Type
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Homecare
8.3.3 Clinics
Chapter 9: North America Painless Blood Glucose Monitoring Device Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Subcutaneous Implant Type
9.4.2 Vacuum Blood Collection Type
9.4.3 Wearable Type
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Homecare
9.5.3 Clinics
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Painless Blood Glucose Monitoring Device Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Subcutaneous Implant Type
10.4.2 Vacuum Blood Collection Type
10.4.3 Wearable Type
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Homecare
10.5.3 Clinics
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Painless Blood Glucose Monitoring Device Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Subcutaneous Implant Type
11.4.2 Vacuum Blood Collection Type
11.4.3 Wearable Type
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Homecare
11.5.3 Clinics
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Painless Blood Glucose Monitoring Device Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Subcutaneous Implant Type
12.4.2 Vacuum Blood Collection Type
12.4.3 Wearable Type
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Homecare
12.5.3 Clinics
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Painless Blood Glucose Monitoring Device Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Subcutaneous Implant Type
13.4.2 Vacuum Blood Collection Type
13.4.3 Wearable Type
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Homecare
13.5.3 Clinics
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Painless Blood Glucose Monitoring Device Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Subcutaneous Implant Type
14.4.2 Vacuum Blood Collection Type
14.4.3 Wearable Type
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Homecare
14.5.3 Clinics
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Painless Blood Glucose Monitoring Device Scope:
|
Report Data
|
Painless Blood Glucose Monitoring Device Market
|
|
Painless Blood Glucose Monitoring Device Market Size in 2022
|
USD 137150 million
|
|
Painless Blood Glucose Monitoring Device CAGR 2023 - 2030
|
3.1%
|
|
Painless Blood Glucose Monitoring Device Base Year
|
2022
|
|
Painless Blood Glucose Monitoring Device Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Nemaura Medical, Occuity, Tianjin Guyufan Biological Technology, GlucoActive, Afon Technology, Gluco-Wise, RSP System, Know Labs, META, Abbott U.S., MediWise, Ascensia Diabetes Care, Dexcom, Inc., Medtronic plc, Sanofi Novo Nordisk, Insulet Corporation, Senseonics.
|
|
Key Segments
|
By Type
Subcutaneous Implant Type
Vacuum Blood Collection Type
Wearable Type
Others
By Applications
Hospitals
Homecare
Clinics
|
Research Methodology
